Skip to main content

Table 5 Comparison of treatment and outcomes among three groups

From: Nonspecific interstitial pneumonia: clinical associations and outcomes

 

SAD-NSIP group

i-NSIP-Ab + group

i-NSIP-Ab-group

Initial therapy

   

 Prednisone, N (%)

9/23(39.1)

30/30(100)

44/44(100)

 Prednisone + immunosuppressive agent, N (%)

14/23(60.9)

0

0

Relapse, N (%)

6/23(26.1)

13/30(4.3)

21/44(47.7)

Emerging autoantibody, N (%)

0

0

3/44(6.8)

classifiable SAD, N (%)

0

2/30(6.7)

3/44(6.8)

PAH, N (%)

1/23(4.3)

1/30(3.3)

1/44(2.3)

Lung infection, N (%)

1/23(4.3)

3/30(10.0)

4/44(9.1)

Death, N (%)

8/23(34.8)

8/30(26.7)

9/44(20.5)

 Underlying disease, N (%)

4/23(17.4)

6/30(20.0)

6/44(13.6)

 Lung infection, N (%)

3/23(13.0)

2/30(6.7)

2/44(4.5)

 Other, N (%)

1/23(4.3)

0

1/44(2.3)